The first stop for professional medicines advice

Regulatory

71 results

RelevanceNewest firstOldest firstTitle
Applied filters

Retention of Pharmacy Records

20 January 2021Summary The 2020 version of the retention of pharmacy records document is now available. Purpose This document, based on one first generated at the request…

Risk Associated with the Outsourcing of the Aseptic Compounding of Parenteral Nutrition (Yellow Cover)

16 December 2016The purpose of this document is to give guidance to those outsourcing PN compounding on the risks in the outsourcing and supply process and to…

Risk assessing Investigational Medicinal Products (IMPs)

12 December 2022Sponsor pharmacy responsibilities when assessing the risk associated with CTIMPs

Risk assessing transcribing for administration

22 February 2022Various factors affect the risks associated with using transcribing for medicines administration.

Semi-acute settings and transcribing

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in semi-acute settings

Supply and/or administration of Controlled Drugs under a Patient Group Direction

16 November 2021This article summarises the legal position on the supply and/or administration of controlled drugs under PGDs.

Supply of aseptically Prepared Doses of IMPs Across Legal Boundaries Version 2 October 2019

11 November 2019This document has been developed by the NHS Quality Assurance Committee and National Pharmacy Clinical Trials Advisory Group with input provided by the MHRA Clinical…

Supporting funding applications for CTIMPs

12 December 2022Sponsor pharmacy role in funding applications and establishing costs for sponsor activities

The legal mechanisms available for giving COVID-19 vaccines and their application

7 January 2021A summary of the different legal mechanisms available, a priority order for the options, and advice on their application to different professional groups.

The role of the sponsor pharmacy in clinical trials of investigational medicinal products (CTIMPs)

12 December 2022Identifying key areas where pharmaceutical expertise is required by sponsors for conducting non-commercial clinical trials